WHEN strain specific tumours are injected into genetically compatible Fl hybrid hosts, they often do not grow as well as in the original parental strain; the frequency of tumour takes is reduced and the latent period is prolonged (Snell, 1958; Hellstrom, 1964) and there is sometimes a reduction in tumour growth rate. This inhibitory Fl hybrid effect is most evident when small tumour inocula are used. We now report a different type of effect in which the inoculation of tumour in a large dose results in accelerated growth in F1 hybrids.
A poorly differentiated squamous cell carcinoma was used; it had originated spontaneously in a female rat of a highly inbred Wistar subline and had subsequently been maintained in this subline by serial subcutaneous transplantation (Baldwin, 1966) . Its growth was investigated in Fl hybrids of both sexes resulting from the cross and reciprocal cross between this subline and inbred rats of the DA (Agouti) strain. These hybrids and control animals of both parental strains were injected subcutaneously in the flank with tumour suspension in doses ranging from 1 X 103 to 3-4 x 106 viable cells, this latter being the highest dose we could reach with available material. Tumour cell suspensions had previously been preprepared by mechanical dissociation of solid tumour from the parental Wistar strain and had been stored in liquid was significantly greater when the mother was of the tumour susceptible Wistar strain. When the tumour dose was reduced to 1 x 104 cells the growth rate was not significantly different from parental strain rats and when smaller doses than this were used the usual inhibitory F 1 hybrid effect was observed. No tumour growth was ever observed in the homozygous DA control rats, even with the highest dose of cells.
Although there is no definite explanation at present for this accelerated tumour growth in Fl hybrids, immunological factors could be involved. It may be that minor antigenic differences existing between the Fl hybrid and the parental strain tumour are sufficient to cause a weak immune response which could, as Prehn (1972) and Baldwin and Pimm (1973) suggest, stimulate tumour growth, perhaps by inflammatory promotion of blood flow. An alternative explanation is suggested by a recent report of preferential tumour growth in Fl hybrid mice: microcytotoxicity tests demonstrated both a serum blocking factor and a cellular immune response against the tumour in the hybrids, whereas tumour resistant parental controls showed only the cellular response (Cotton, Rice and Esber, 1973) . A similar blocking factor might be responsible for the accelerated growth in our system.
One curious feature of the accelerated tumour growth in this system is that it is much more obvious when the mother of the hybrid is of the tumour susceptible strain, suggesting that some factor in the maternal environment is implicated in the production of this effect. In this context, it is interesting to note that the iinhibitory Fl hybrid effect may be much reduced or even abolished when the mother of the hybrid is of the tumour susceptible strain (Oth et al., 1968; Sanford and Soo, 1971) or when a tumour susceptible foster mother is used (Oth et al., 1968) .
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